ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

38.14
Delayed Data
As of Mar 03
 -0.09 / -0.24%
Today’s Change
15.64
Today|||52-Week Range
38.54
+20.13%
Year-to-Date

Today’s Trading

Previous close38.23
Today’s open38.22
Day’s range37.94 - 38.54
Volume861,565
Average volume (3 months)1,317,961
Market cap$3.8B
Dividend yield--
Data as of 3:59pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-7.11%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc-2.10-1.65%
GRFSGrifols SA+0.11+0.35%
NBIXNeurocrine Bioscienc...+0.43+1.06%
SGENSeattle Genetics Inc-0.85-2.36%
Data as of 3:59pm ET, 03/03/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account